Упрощенная HTML-версия
162
95.Livingston D.H. Prevention of ventilator-associated pneumonia / D.H. Liv-
ingston // Am. J. Surd. - 2000. - Vol. 179. - p. 12-17.
96.Loanas M. Microbial investigation in ventilator-associated pneumonia / M.
Loanas, R. Ferrer, J. Angrill, M. Ferrer, A. Torres // Eur. Respir. J. – 2001. –
Vol. 17. – p. 791-801.
97.Lobo S.M.A. C – reactive protein levels correlate with mortality and organ
failure in critically III patients / S.M.A. Lodo, F. R.M. Lodo, et al. // Chest. –
2003. – Vol. 123. – p. 2043-2049.
98.Long M.N. Prospective, randomized study of ventilator-associated pneumo-
nia in patients with one versus three ventilator circuit changer per week /
M.N. Long, G. Wickstrom, A. Grimes, C.F. Benton, B. Belcher, A.M.
Stamm // Infect. Control. Hosp. Epidemiol. - 1996. - Vol. 17. - p. 14-19.
99.Lynch J.P. Hospital-Acquired Pneumonia: Risk Factors, Microbiology and
Treatment / J.P.Lynch // Chest. - 2001. - Vol. 119. - p. 373-384.
100.Markowicz P. Multicenter prospective study of ventilator – associated
pneumonia during acute respiratory distress syndrome / P. Markowicz, M.
Wolff, K. Djedaini, et al. // Am. J. Respir. Crit. Care Med. – 2000. – Vol.
61. – p. 1942-1948.
101.Matthay M.A. Acute lung injury / M.A. Matthay // Chest. – 1999. – Vol.
116. – p. 119-126.
102.Martin T.R. Effect of leukotriene B4 in the human lung: recruiment of neu-
trophils into the alveolar space without a change in protein permeability /
T.R. Martin // J. Clin. Invest. - 1989. – Vol. 84. – p. 1609-1619.
103.Marty C. Circulating interleukin-8 concentrations in patiens with multiple
organ failure of septic and nonseptic origin / C. Marty, B. Misset, F. Tami-
on // Critical.Care Medicine. – 1994. – Vol. 22. – p. 673-679.
104.Menzies R. Determinants of weaning and survival among patients with
COPD who require mechanical ventilation for acute respiratory failure / R.
Menzies, W. Gibbons // Chest. – 1989. – Vol. 95. – p. 398-405.